Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Nicolas Goderniaux"'
Novel proposed cutoff values for anatabine and anabasine in differentiating smokers from non-smokers
Autor:
Marie-Lise Colsoul, Nicolas Goderniaux, Sabrina Onorati, Stéphanie Dupuis, Jacques Jamart, Dominique Vanpee, Ivan Berlin, Laurence Galanti
Publikováno v:
Clinical biochemistry, Vol. 116, p. 128-131 (2023)
Anatabine and anabasine are two tobacco alkaloids used to differentiate between tobacco users and abstainers, including users of nicotine replacement therapy. Cutoff values (>2 ng/mL for both alkaloids) have not been revised since their implementatio
Autor:
Marie‐Lise Colsoul, Nicolas Goderniaux, Sabrina Onorati, Stéphanie Dupuis, Jacques Jamart, Dominique Vanpee, Ivan Berlin, Laurence Galanti
Publikováno v:
European journal of clinical investigation, p. e13996 (2023)
Tobacco use is known to be involved in the development of cardiovascular diseases, which leads to premature mortality. Endothelial dysfunction, the first step in this process, was shown induced by smoking. It is reported that quitting smoking could r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62bf2e5091dd41f61d4a8e58f3517cff
https://hdl.handle.net/2078.1/274123
https://hdl.handle.net/2078.1/274123
Autor:
Marie-Lise Colsoul, Nicolas Goderniaux, Sabrina Onorati, Stéphanie Dupuis, Jacques Jamart, Dominique Vanpee, Ivan Berlin, Laurence Galanti
Publikováno v:
European Journal of Environment and Public Health. 7:em0136
Aims: Tobacco use is involved in endothelial dysfunction, a key marker of cardiovascular diseases. The contribution of tobacco use in their development is assessed by endothelial dysfunction-related biomarkers in smokers and non-smokers. Methods: 138
Autor:
Benoît Bihin, Marie-Lise Colsoul, Laura Soumoy, M Closset, Jacques Jamart, Jean-Daniel Hecq, Laurence Galanti, Nicolas Goderniaux, Sabrina Onorati, Pascal Odou
Publikováno v:
Journal of chemotherapy, Vol. 33, no. 7, p. 486-491 (2021)
Management of chemotherapies is a strategic issue for european healthcare. Dose-banding enables to reduce waiting time of patients in day care units and drug wastage. The aim of this study was to assess the stability of 5-Fluorouracile (5-FU) at stan
Autor:
Mélanie Closset, Marie-Lise Colsoul, Nicolas Goderniaux, Benoît Bihin, Jacques Jamart, Sabrina Onorati, Laura Soumoy, Jean-Daniel Hecq, Pascal Odou, Laurence Galanti
Publikováno v:
Journal of pharmaceutical and biomedical analysis, Vol. 227, p. 115290 (2023)
Gemcitabine is an analogue of cytidine arabinoside, used alone or in combination chemotherapy to treat various type of cancer. The dose-banding of gemcitabine provides the opportunity to anticipate the preparation of this anticancer drug on condition
Autor:
Mélanie Closset, Sabrina Onorati, Marie-Lise Colsoul, Nicolas Goderniaux, Benoît Bihin, Jacques Jamart, Laura Soumoy, Jean-Daniel Hecq, Pascal Odou, Laurence Galanti
Publikováno v:
Journal of Oncology Pharmacy Practice
Journal of Oncology Pharmacy Practice, 2023, Journal of Oncology Pharmacy Practice, pp.10781552231152618. ⟨10.1177/10781552231152618⟩
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, p. 10781552231152618 (2023)
Journal of Oncology Pharmacy Practice, 2023, Journal of Oncology Pharmacy Practice, pp.10781552231152618. ⟨10.1177/10781552231152618⟩
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, p. 10781552231152618 (2023)
Background Chemotherapy doses are usually prescribed on the basis of body surface area but dose banding is emerging as an efficient alternative. Dose banding presents the possibility of in-advance preparation in a Centralized Intravenous Admixture Se
Autor:
Laurence Galanti, Nicolas Goderniaux, M Closset, Jacques Jamart, Laura Soumoy, Benoît Bihin, Jean-Daniel Hecq, Marie-Lise Colsoul, Pascal Odou
Publikováno v:
Journal of oncology pharmacy practice, Vol. 27, no. 6, p. 1328-1332 (2021)
Background Patients undergoing chemotherapeutic treatment are currently treated by a concomittent infusion of alizapride and ondansetron. To optimise the procedure and to ensure patients’ safety, the admixture could be prepared in advance by the Ce
Autor:
Laurence Galanti, Océane Charles, Benoît Bihin, Jean-Daniel Hecq, Jacques Jamart, Nicolas Goderniaux, Laura Soumoy, Marie-Lise Colsoul
Publikováno v:
European Journal of Hospital Pharmacy, Vol. 27, no. e1, p. e74-e78 (2020)
Eur J Hosp Pharm
Eur J Hosp Pharm
Background and objective Infusion containing paracetamol, alizapride, ketorolac and tramadol is used after a general anaesthesia in order to limit pain, fever and nausea. Currently, these infusions are prepared according to demand in the anaesthesia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f7eff2ae38191fb1a35191fbf0b0760
https://hdl.handle.net/2078.1/216857
https://hdl.handle.net/2078.1/216857
Autor:
Laura Defrene, Benoît Bihin, Laura Soumoy, Jacques Jamart, Laurence Galanti, Jean-Daniel Hecq, Nicolas Goderniaux, Marie-Lise Colsoul
Publikováno v:
Journal of Pharmaceutical and Pharmacological Sciences, Vol. 3, no. 01 (2019) (2019)
Background and Objective: Patients in palliative care are injected with a sedation infusion containing morphine, ketamine and lorazepam in order to relieve pain. This infusion is prepared by the nursing staff according to demand, but the awareness of
Autor:
Colsoul, Marie‐Lise1 (AUTHOR) marie‐lise.colsoul@uclouvain.be, Goderniaux, Nicolas1 (AUTHOR), Onorati, Sabrina1 (AUTHOR), Dupuis, Stéphanie1 (AUTHOR), Jamart, Jacques2 (AUTHOR), Vanpee, Dominique3 (AUTHOR), Berlin, Ivan4 (AUTHOR), Galanti, Laurence1 (AUTHOR)
Publikováno v:
European Journal of Clinical Investigation. Aug2023, Vol. 53 Issue 8, p1-10. 10p.